(DEA) Eerly Govt Ppty - Ratings and Ratios
Real Estate, Lease, Federal Agency, Property, Portfolio
DEA EPS (Earnings per Share)
DEA Revenue
Description: DEA Eerly Govt Ppty
Eerly Govt Ppty Inc (NYSE:DEA), a Diversified REIT, operates in the United States. The companys performance can be evaluated through various key performance indicators (KPIs) and economic drivers.
To assess DEAs financial health, we can examine its income statement, particularly the quarterly Income Tax Expense, which is a crucial component in determining the companys net income. A thorough analysis of this expense can reveal the companys tax strategy and its impact on profitability.
Key drivers influencing DEAs performance include rental income growth, occupancy rates, and the overall demand for healthcare facilities, as the company primarily invests in medical office buildings and healthcare-related properties. The REITs ability to generate consistent cash flows and maintain a stable dividend payout is critical to its attractiveness to investors.
From a valuation perspective, DEAs Price-to-Earnings (P/E) ratio of 57.74 and Forward P/E of 43.10 suggest that the market has certain expectations regarding the companys future earnings growth. Additionally, the Return on Equity (RoE) of 1.34% indicates that DEAs profitability is relatively low, which may be a concern for investors seeking higher returns.
To gain a deeper understanding of DEAs stock performance, we can look at its market capitalization of $1.114 billion, which categorizes it as a mid-cap stock. The stocks beta of 0.902 indicates that it is slightly less volatile than the overall market. Furthermore, the Average True Range (ATR) of 0.49, representing a 2.21% daily price movement, provides insight into the stocks short-term volatility.
Investors should also consider the broader economic landscape, including interest rates, GDP growth, and the overall healthcare industry trends, as these factors can significantly impact DEAs business operations and stock performance. A comprehensive analysis of these factors can help investors make more informed decisions about DEAs potential as a investment opportunity.
DEA Stock Overview
| Market Cap in USD | 1,163m |
| Sub-Industry | Diversified REITs |
| IPO / Inception | 2015-02-06 |
DEA Stock Ratings
| Growth Rating | -70.5% |
| Fundamental | 65.9% |
| Dividend Rating | 66.9% |
| Return 12m vs S&P 500 | -35.6% |
| Analyst Rating | 3.0 of 5 |
DEA Dividends
| Dividend Yield 12m | 12.16% |
| Yield on Cost 5y | 7.55% |
| Annual Growth 5y | 0.38% |
| Payout Consistency | 98.2% |
| Payout Ratio | 11.2% |
DEA Growth Ratios
| Growth Correlation 3m | 46% |
| Growth Correlation 12m | -82.8% |
| Growth Correlation 5y | -86.7% |
| CAGR 5y | -11.27% |
| CAGR/Max DD 3y | -0.25 |
| CAGR/Mean DD 3y | -0.56 |
| Sharpe Ratio 12m | -0.99 |
| Alpha | 0.00 |
| Beta | 0.947 |
| Volatility | 24.48% |
| Current Volume | 306.5k |
| Average Volume 20d | 523k |
| Stop Loss | 22.6 (-3%) |
| Signal | 0.55 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (17.2m TTM) > 0 and > 6% of Revenue (6% = 19.0m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -0.27pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -383.1% (prev -63.28%; Δ -319.8pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 144.0m > Net Income 17.2m (YES >=105%, WARN >=100%) |
| Net Debt (1.17b) to EBITDA (191.1m) ratio: 6.11 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.06 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (44.2m) change vs 12m ago 7.15% (target <= -2.0% for YES) |
| Gross Margin 65.21% (prev 64.66%; Δ 0.55pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 9.94% (prev 9.80%; Δ 0.14pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.23 (EBITDA TTM 191.1m / Interest Expense TTM 70.8m) >= 6 (WARN >= 3) |
Altman Z'' -1.97
| (A) -0.36 = (Total Current Assets 80.2m - Total Current Liabilities 1.29b) / Total Assets 3.36b |
| (B) 0.04 = Retained Earnings (Balance) 139.1m / Total Assets 3.36b |
| (C) 0.03 = EBIT TTM 87.3m / Avg Total Assets 3.18b |
| (D) 0.07 = Book Value of Equity 134.9m / Total Liabilities 1.97b |
| Total Rating: -1.97 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.90
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield 3.55% = 1.78 |
| 3. FCF Margin 45.59% = 7.50 |
| 4. Debt/Equity 2.17 = 0.52 |
| 5. Debt/Ebitda 15.15 = -2.50 |
| 6. ROIC - WACC (= 2.66)% = 3.33 |
| 7. RoE 1.30% = 0.11 |
| 8. Rev. Trend 75.08% = 5.63 |
| 9. EPS Trend 30.76% = 1.54 |
What is the price of DEA shares?
Over the past week, the price has changed by +2.24%, over one month by +6.88%, over three months by +3.51% and over the past year by -23.49%.
Is Eerly Govt Ppty a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DEA is around 21.64 USD . This means that DEA is currently overvalued and has a potential downside of -7.16%.
Is DEA a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 4
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the DEA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 24.1 | 3.3% |
| Analysts Target Price | 24.1 | 3.3% |
| ValueRay Target Price | 24.4 | 4.5% |
Last update: 2025-09-03 04:35
DEA Fundamental Data Overview
CCE Cash And Equivalents = 4.70m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 60.2368
P/E Forward = 54.6448
P/S = 3.6008
P/B = 0.778
Beta = 0.902
Revenue TTM = 315.9m USD
EBIT TTM = 87.3m USD
EBITDA TTM = 191.1m USD
Long Term Debt = 1.72b USD (from longTermDebt, last quarter)
Short Term Debt = 1.17b USD (from shortTermDebt, last quarter)
Debt = 2.89b USD (Calculated: Short Term 1.17b + Long Term 1.72b)
Net Debt = 1.17b USD (from netDebt column, last quarter)
Enterprise Value = 4.05b USD (1.16b + Debt 2.89b - CCE 4.70m)
Interest Coverage Ratio = 1.23 (Ebit TTM 87.3m / Interest Expense TTM 70.8m)
FCF Yield = 3.55% (FCF TTM 144.0m / Enterprise Value 4.05b)
FCF Margin = 45.59% (FCF TTM 144.0m / Revenue TTM 315.9m)
Net Margin = 5.45% (Net Income TTM 17.2m / Revenue TTM 315.9m)
Gross Margin = 65.21% ((Revenue TTM 315.9m - Cost of Revenue TTM 109.9m) / Revenue TTM)
Tobins Q-Ratio = 30.04 (Enterprise Value 4.05b / Book Value Of Equity 134.9m)
Interest Expense / Debt = 0.65% (Interest Expense 19.0m / Debt 2.89b)
Taxrate = -3.67% (set to none) (-156.0k / 4.25m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 0.06 (Total Current Assets 80.2m / Total Current Liabilities 1.29b)
Debt / Equity = 2.17 (Debt 2.89b / last Quarter total Stockholder Equity 1.33b)
Debt / EBITDA = 15.15 (Net Debt 1.17b / EBITDA 191.1m)
Debt / FCF = 20.10 (Debt 2.89b / FCF TTM 144.0m)
Total Stockholder Equity = 1.33b (last 4 quarters mean)
RoA = 0.51% (Net Income 17.2m, Total Assets 3.36b )
RoE = 1.30% (Net Income TTM 17.2m / Total Stockholder Equity 1.33b)
RoCE = 2.86% (Ebit 87.3m / (Equity 1.33b + L.T.Debt 1.72b))
RoIC = 2.66% (Ebit 87.3m / (Assets 3.36b - Current Assets 80.2m))
WACC = unknown (E(1.16b)/V(4.06b) * Re(9.50%)) + (D(2.89b)/V(4.06b) * Rd(0.65%) * (1-Tc(none)))
Shares Correlation 3-Years: -6.06 | Cagr: -6.36%
Discount Rate = 9.50% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.00% ; FCFE base≈141.0m ; Y1≈148.5m ; Y5≈174.6m
Fair Price DCF = 52.36 (DCF Value 2.37b / Shares Outstanding 45.4m; 5y FCF grow 5.74% → 3.0% )
EPS Correlation: 30.76 | EPS CAGR: 122.3% | SUE: 1.57 | # QB: 1
Revenue Correlation: 75.08 | Revenue CAGR: 4.29% | SUE: N/A | # QB: None
Additional Sources for DEA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle